Page last updated: 2024-10-18

hydroquinone and Vitiligo

hydroquinone has been researched along with Vitiligo in 17 studies

Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.

Research Excerpts

ExcerptRelevanceReference
"Galangin, the main active component of Alpinia officinarum Hance, was tested in a mouse model of vitiligo induced in C57BL/6 mice by the topical application of 2 mL of 2."7.80The effects of galangin on a mouse model of vitiligo induced by hydroquinone. ( Gao, L; Ge, CH; Huo, SX; Liu, XM; Peng, XM; Yan, M; Zhao, PP, 2014)
"Chemical leukoderma is an acquired type of vitiligo that can be initiated by various exogenous chemicals such as hydroquinone (HQ), rhododendrol (RD), or 4-tertiary butyl phenol (4-TBP)."3.91Keratinocyte-derived IL-36γ plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. ( Ahn, S; An, S; Choi, D; Choi, H; Choi, J; Jin, SH; Kim, HJ; Lee, E; Noh, M; Pyo, JJ; Shin, JC, 2019)
"Galangin, the main active component of Alpinia officinarum Hance, was tested in a mouse model of vitiligo induced in C57BL/6 mice by the topical application of 2 mL of 2."3.80The effects of galangin on a mouse model of vitiligo induced by hydroquinone. ( Gao, L; Ge, CH; Huo, SX; Liu, XM; Peng, XM; Yan, M; Zhao, PP, 2014)
" It is assumed that acrylates induced contact vitiligo, but the dental acrylics may have also contained other chemicals (eg, hydroquinone or phenolic substances) capable of causing vitiligo."3.70Contact leukoderma caused by patch testing with dental acrylics. ( Estlander, T; Kanerva, L, 1998)
"Traditionally, the treatment of vitiligo has focused on pharmacologic interventions, but nearly half of all treated patients fail to respond successfully."2.48Advanced treatment modalities for vitiligo. ( Cohen, GF; Paghdal, KV; Patel, NS, 2012)
"Vitiligo is a relatively common acquired skin depigmentary disease with a complex presentation, therapy, and etiology."2.47Vitiligo: current medical and scientific understanding. ( Boissy, RE; Nordlund, JJ, 2011)
"The two autoimmune diseases are not only linked by a concordance of clinical presentations and an autoimmune/oxidative stress-mediated toxicity pathogenesis but also by an apparent biochemical commonality."1.51Vitiligo and Hashimoto's thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis. ( Bellanti, JA; Calderone, R; Li, D; Liang, G, 2019)
"Vitiligo is characterized by depigmentation in large or small areas of the skin."1.27Vitiligo. ( Dunn, JF, 1986)

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19903 (17.65)18.7374
1990's4 (23.53)18.2507
2000's1 (5.88)29.6817
2010's9 (52.94)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harris, JE1
Huo, SX2
Wang, Q1
Liu, XM2
Ge, CH2
Gao, L2
Peng, XM2
Yan, M2
Kim, H1
Park, CS1
Lee, AY1
Zubair, R1
Lyons, AB1
Vellaichamy, G1
Peacock, A1
Hamzavi, I1
Li, D1
Liang, G1
Calderone, R1
Bellanti, JA1
Pyo, JJ1
Ahn, S1
Jin, SH1
An, S1
Lee, E1
Choi, J1
Shin, JC1
Choi, H1
Kim, HJ1
Choi, D1
Noh, M1
Zhao, PP1
Boissy, RE1
Nordlund, JJ1
Patel, NS1
Paghdal, KV1
Cohen, GF1
CANIZARES, O1
URIBE JARAMILLO, F1
KERDEL VEGAS, F1
Fisher, AA2
Kanerva, L1
Estlander, T1
Lerner, MR1
Fitzpatrick, TB1
Halder, RM1
Hawk, JL1
Kim, YJ1
Chung, BS1
Choi, KC1
Das, M1
Tandon, A1
Dunn, JF1

Reviews

4 reviews available for hydroquinone and Vitiligo

ArticleYear
Chemical-Induced Vitiligo.
    Dermatologic clinics, 2017, Volume: 35, Issue:2

    Topics: Autoimmunity; Catechols; Hair Dyes; Humans; Hydroquinones; Hypopigmentation; Phenols; Phenylenediami

2017
What's New in Pigmentary Disorders.
    Dermatologic clinics, 2019, Volume: 37, Issue:2

    Topics: alpha-MSH; Antifibrinolytic Agents; Bimatoprost; Dermatologic Agents; Humans; Hydroquinones; Inflamm

2019
Vitiligo: current medical and scientific understanding.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2011, Volume: 146, Issue:1

    Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Genetic Association Studies; Genetic Predisposition to

2011
Advanced treatment modalities for vitiligo.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012, Volume: 38, Issue:3

    Topics: Dermabrasion; Humans; Hydroquinones; Khellin; Lasers, Excimer; Low-Level Light Therapy; Melanocytes;

2012

Other Studies

13 other studies available for hydroquinone and Vitiligo

ArticleYear
The Effect of Butin on the Vitiligo Mouse Model Induced by Hydroquinone.
    Phytotherapy research : PTR, 2017, Volume: 31, Issue:5

    Topics: Animals; Benzopyrans; Cell Survival; Epidermis; Hair Follicle; Humans; Hydroquinones; Male; Malondia

2017
Reduced Nrf2 activation in PI3K phosphorylation-impaired vitiliginous keratinocytes increases susceptibility to ROS-generating chemical-induced apoptosis.
    Environmental toxicology, 2017, Volume: 32, Issue:12

    Topics: Adolescent; Adult; Antioxidants; Apoptosis; Cell Survival; Cells, Cultured; Epidermis; Female; Gene

2017
Vitiligo and Hashimoto's thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesis.
    Medical hypotheses, 2019, Volume: 128

    Topics: Animals; Autoimmune Diseases; Autoimmunity; Benzoquinones; Disease Models, Animal; Hashimoto Disease

2019
Keratinocyte-derived IL-36γ plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes.
    Archives of toxicology, 2019, Volume: 93, Issue:8

    Topics: Cytokines; Humans; Hydroquinones; Hypopigmentation; Interleukin-1; Interleukin-17; Keratinocytes; Me

2019
The effects of galangin on a mouse model of vitiligo induced by hydroquinone.
    Phytotherapy research : PTR, 2014, Volume: 28, Issue:10

    Topics: Alpinia; Animals; Flavonoids; Hydroquinones; Male; Malondialdehyde; Melanins; Melanocytes; Methoxsal

2014
Leukomelanoderma subsequent to the application of monobenzyl ether of hydroquinone; a vitiligoid reaction observed in Colombia and Venezuela.
    A.M.A. archives of dermatology, 1958, Volume: 77, Issue:2

    Topics: Colombia; Ether; Ethers; Hydroquinones; Phenols; Venezuela; Vitiligo

1958
Differential diagnosis of idiopathic vitiligo from contact leukoderma. Part II: Leukoderma due to cosmetics and bleaching creams.
    Cutis, 1994, Volume: 53, Issue:5

    Topics: Adult; Butylated Hydroxytoluene; Catechols; Cosmetics; Dermatitis, Contact; Diagnosis, Differential;

1994
Differential diagnosis of idiopathic vitiligo. Part III: Occupational leukoderma.
    Cutis, 1994, Volume: 53, Issue:6

    Topics: Anti-Infective Agents, Local; Dermatitis, Occupational; Diagnosis, Differential; Humans; Hydroquinon

1994
Contact leukoderma caused by patch testing with dental acrylics.
    American journal of contact dermatitis : official journal of the American Contact Dermatitis Society, 1998, Volume: 9, Issue:3

    Topics: Acrylic Resins; Dental Materials; Dermatitis, Allergic Contact; Dermatitis, Occupational; Female; Ha

1998
Discussion of a case of vitiligo.
    Photodermatology, photoimmunology & photomedicine, 1999, Volume: 15, Issue:1

    Topics: Adrenal Cortex Hormones; Child; Humans; Hydroquinones; Male; PUVA Therapy; Vitiligo

1999
Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2001, Volume: 27, Issue:11

    Topics: Aged; Female; Humans; Hydroquinones; Laser Coagulation; Melanocytes; PUVA Therapy; Vitiligo

2001
Occupational vitiligo.
    Contact dermatitis, 1988, Volume: 18, Issue:3

    Topics: Adult; Dermatitis, Occupational; Humans; Hydroquinones; Male; Vitiligo

1988
Vitiligo.
    American family physician, 1986, Volume: 33, Issue:5

    Topics: Adolescent; Adult; Autoimmune Diseases; Child; Child, Preschool; Diagnosis, Differential; Female; Fl

1986